Given that HSP990 has already been used in a clinical trial, this study sought to develop and evaluate [11C]HSP990 (Fig. 1) as a Hsp90 PET tracer to elucidate saturable Hsp90 binding and its role in health and neurodegenerative disease and to advance clinical translation. Here, HSP90AA1 is linked to neurodegenerative disease.